2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Pathophysiological mechanisms of bone mass loss for osteoporosis prevalence in Parkinson’s disease

L.A. Leandro, H.A.G. Teive (Curitiba, Brazil)
Patient case reports supporting a long-term effect of sub-anesthetic ketamine infusion in reducing L-DOPA-induced dyskinesias

S.J. Sherman, T. Falk (Tucson, AZ, USA)
Patient experiences following Parkinson’s disease treatment with inhaled levodopa: Results from a Phase 2b study

P. LeWitt, A. Niyazov, A. Sedkov, H. Murck, A. Guo (West Bloomfield, MI, USA)
Patient reported outcomes in Parkinson’s disease (PRO-PD) rating scale validation

L.K. Mischley (Kenmore, WA, USA)
Patient satisfaction with flexible botulinum toxin injection intervals – Preliminary results of a telephone survey

C. Linder, S. Macher, E. Auff, T. Sycha (Vienna, Austria)
Patient-centered educational intervention using hand-held electronic devices

N. Hellmers, A. Hanineva, J.C. Stribling, J. Carter, C. Henchliffe (New York, NY, USA)
Patient-centered outcomes of DBS in Parkinson’s disease

J. Karl, B. Ouyang, K. Colletta, L. Verhagen (Chicago, IL, USA)
Patients’ employment status and quality of life affect caregivers burden in Parkinson’s disease in Singapore

K.M. Prakash, N.V. Nadkarni, W.K. Lye, E.C. Lim, E.K. Tan (Singapore, Singapore)
PD COMM Pilot: A pilot randomised controlled trial of Lee Silverman voice treatment (LSVT) versus NHS speech and language therapy versus no intervention in Parkinson’s

C.M. Sackley, S. Patel, R. Woolley, N.J. Ives, C.E. Rick, F. Dowling, K. Wheatley, C. Smith, M. Brady, C.E. Clarke (London, United Kingdom)
Perception of the visual vertical is not impaired in patients with idiopathic cervical dystonia

J. De Pauw, R. Mercelis, W. Saeys, S. Truijen, P. Cras, W. De Hertogh (Antwerp, Belgium)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z